Transcorneal Electrical Stimulation
Cross-source consensus on Transcorneal Electrical Stimulation from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Benefits
Background
Evidence quality
Highlighted claims
- Transcorneal electrical stimulation delivers weak biphasic current pulses through a corneal thread electrode. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
- TES clinical evidence comes mainly from the OkuStim System, which has been marketed for retinitis pigmentosa since 2011. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
- TES is intended as a neuroprotective adjunct to standard intraocular pressure-lowering treatment, not a replacement. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
- Existing clinical evidence for TES in glaucoma is limited by small samples, mixed patient groups, and inconsistent stimulation protocols. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
- TES is proposed to activate protective signalling pathways, including release of endogenous neuroprotective substances and modulation of inflammatory pathways. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol
- In retinitis pigmentosa studies, TES effects on visual field and electroretinogram parameters were generally reversible after stopping stimulation. — Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol